What if we could restore brain function for the tens of millions of individuals who suffer from permanent brain damage?
Strokes, traumas, neurodegeneration, and tumors can all cause permanent brain damage, but as of now there are no treatments that enable affected individuals to regain lost abilities. Consequently, they remain dependent on costly care for the rest of their lives.
The aim of the Brain Repair program is to develop methods for replacing damaged brain tissue, enabling patients to regain lost function. The success of BE Therapeutics will bring relief to the millions of people world-wide suffering from permanent brain damage.
Company Details
- Employees
- 6
- Founded
- -
- Address
- New York City Metropolitan Area, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- New York City Metropolitan Area
Be Therapeutics Questions
Be Therapeutics's LinkedIn profile is https://www.linkedin.com/company/be-tx
Be Therapeutics has
6 employees.
View email and phone details for 6
employees at Be Therapeutics.
Be Therapeutics's industry is
Biotechnology Research
Be Therapeutics's top competitors are
Be Biopharma,
Sapience Therapeutics, Inc.,
Bioharmony Therapeutics,
Chan Zuckerberg Initiative,
Apollo Ventures,
Apollo Health Ventures,
Alkyon Therapeutics,
Hydradao,
Novabioassays,
Phenocell (Axol Bioscience Ltd.).
Be Therapeutics's categories are Biotechnology Research
Be Therapeutics's founding year is 2023
